Neovascularization Patterns in Corneal Graft Rejection
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01695655|
Recruitment Status : Completed
First Posted : September 28, 2012
Last Update Posted : March 15, 2017
Corneal transplantation is the most commonly performed human tissue transplant worldwide. Over 40,000 corneal transplants occur in the US each year. .
This study will determine specific corneal neovascularization (CN) patterns in human corneal allograft recipients to determine the characteristics that worsen the prognosis for graft survival. We will test the hypothesis that specific characteristics of CN are prognostic for corneal allograft rejection.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||44 participants|
|Official Title:||Neovascularization Patterns in Corneal Graft Rejection|
|Study Start Date :||November 2007|
|Actual Primary Completion Date :||December 2015|
|Actual Study Completion Date :||December 2016|
Subjects undergoing penetrating keratoplasty
- Corneal graft rejection [ Time Frame: 0 to 2 years after transplant ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01695655
|United States, Michigan|
|Kellogg Eye Center|
|Ann Arbor, Michigan, United States, 48105|
|Principal Investigator:||Roni Shtein, MD, MS||University Of Michigam Kellogg Eye Center|